Laurence Tam
Stock Analyst at Morgan Stanley
(1.56)
# 3,419
Out of 4,476 analysts
37
Total ratings
54.2%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Laurence Tam
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Maintained: Buy | $50.00 | $37.56 | +33.12% | 8 | Jun 8, 2026 | |
| HKG: 6821 Asymchem Laboratories (Tianjin) Co., Ltd. | Maintained: Hold | $120.00 | $118.70 | +1.10% | 1 | Apr 15, 2026 | |
| HKG: 2268 WuXi XDC Cayman Inc. | Maintained: Buy | $60.00 → $88.00 | $61.70 | +42.63% | 2 | Nov 21, 2025 | |
| HKG: 0570 China Traditional Chinese Medicine Holdings Co. Limited | Maintained: Sell | $1.60 | $1.41 | +13.48% | 7 | Oct 17, 2025 | |
| HKG: 1099 Sinopharm Group Co. Ltd. | Maintained: Buy | $25.00 → $22.50 | $16.74 | +34.41% | 4 | Aug 22, 2025 | |
| HKG: 3880 Medtide Inc. | Initiated Coverage: Hold | $38.00 | $22.00 | +72.73% | 1 | Aug 6, 2025 | |
| HKG: 0874 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | Maintained: Hold | $21.70 → $21.40 | $14.92 | n/a | 4 | Dec 23, 2024 | |
| HKG: 2607 Shanghai Pharmaceuticals Holding Co., Ltd | Maintained: Buy | $17.50 → $17.00 | $11.74 | n/a | 3 | Dec 23, 2024 | |
| HKG: 3320 China Resources Pharmaceutical Group Limited | Maintained: Buy | $7.80 → $7.50 | $4.50 | n/a | 3 | Sep 17, 2024 | |
| HKG: 9989 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | Maintained: Hold | $3.50 | $4.14 | n/a | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6.10 | $3.34 | n/a | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17.00 → $15.00 | $6.47 | n/a | 2 | Mar 15, 2024 |
WuXi Biologics (Cayman) Inc.
Jun 8, 2026
Maintained: Buy
Price Target: $50.00
Current: $37.56
Upside: +33.12%
Asymchem Laboratories (Tianjin) Co., Ltd.
Apr 15, 2026
Maintained: Hold
Price Target: $120.00
Current: $118.70
Upside: +1.10%
WuXi XDC Cayman Inc.
Nov 21, 2025
Maintained: Buy
Price Target: $60.00 → $88.00
Current: $61.70
Upside: +42.63%
China Traditional Chinese Medicine Holdings Co. Limited
Oct 17, 2025
Maintained: Sell
Price Target: $1.60
Current: $1.41
Upside: +13.48%
Sinopharm Group Co. Ltd.
Aug 22, 2025
Maintained: Buy
Price Target: $25.00 → $22.50
Current: $16.74
Upside: +34.41%
Medtide Inc.
Aug 6, 2025
Initiated Coverage: Hold
Price Target: $38.00
Current: $22.00
Upside: +72.73%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Dec 23, 2024
Maintained: Hold
Price Target: $21.70 → $21.40
Current: $14.92
Upside: n/a
Shanghai Pharmaceuticals Holding Co., Ltd
Dec 23, 2024
Maintained: Buy
Price Target: $17.50 → $17.00
Current: $11.74
Upside: n/a
China Resources Pharmaceutical Group Limited
Sep 17, 2024
Maintained: Buy
Price Target: $7.80 → $7.50
Current: $4.50
Upside: n/a
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Sep 17, 2024
Maintained: Hold
Price Target: $3.50
Current: $4.14
Upside: n/a
Apr 17, 2024
Maintained: Hold
Price Target: $6.10
Current: $3.34
Upside: n/a
Mar 15, 2024
Maintained: Buy
Price Target: $17.00 → $15.00
Current: $6.47
Upside: n/a